See more : Renault SA (RNSDF) Income Statement Analysis – Financial Results
Complete financial analysis of The Cannabist Company Holdings Inc. (CBSTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Cannabist Company Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Sagicor Financial Company Ltd. (SFC.TO) Income Statement Analysis – Financial Results
- Barryroe Offshore Energy plc (PVDRF) Income Statement Analysis – Financial Results
- Ragnar Metals Limited (RAG.AX) Income Statement Analysis – Financial Results
- Glenmark Pharmaceuticals Limited (GLENMARK.NS) Income Statement Analysis – Financial Results
- Newgen Software Technologies Limited (NEWGEN.NS) Income Statement Analysis – Financial Results
The Cannabist Company Holdings Inc. (CBSTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannabistcompany.com
About The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 511.33M | 491.31M | 456.03M | 188.99M | 79.26M | 347.78K |
| Cost of Revenue | 331.36M | 355.18M | 309.11M | 136.30M | 65.79M | 2.29M |
| Gross Profit | 179.97M | 136.13M | 146.92M | 52.68M | 13.47M | -1.94M |
| Gross Profit Ratio | 35.20% | 27.71% | 32.22% | 27.88% | 16.99% | -558.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 158.85M | 203.69M | 179.48M | 130.22M | 103.98M | 0.00 |
| Selling & Marketing | 5.39M | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
| SG&A | 164.23M | 209.23M | 184.62M | 137.13M | 109.77M | 0.00 |
| Other Expenses | 120.98M | -3.04M | -1.33M | 368.00K | 0.00 | -807.59K |
| Operating Expenses | 285.21M | 209.23M | 184.62M | 137.13M | 109.77M | 807.59K |
| Cost & Expenses | 616.57M | 564.41M | 493.73M | 273.43M | 175.56M | 3.10M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.24M | 0.00 |
| Interest Expense | 54.87M | 53.90M | 30.01M | 6.34M | 0.00 | 0.00 |
| Depreciation & Amortization | 62.73M | 81.43M | 52.54M | 20.69M | 15.54M | 0.00 |
| EBITDA | -52.24M | -282.36M | -63.14M | -115.66M | -95.21M | -2.75M |
| EBITDA Ratio | -10.22% | 1.69% | 3.25% | -33.74% | -101.89% | -790.95% |
| Operating Income | -105.24M | -73.10M | -37.70M | -84.45M | -96.30M | -2.75M |
| Operating Income Ratio | -20.58% | -14.88% | -8.27% | -44.69% | -121.50% | -790.95% |
| Total Other Income/Expenses | -63.66M | -16.45M | -36.35M | -55.63M | 261.95K | 0.00 |
| Income Before Tax | -168.90M | -415.55M | -145.42M | -143.02M | -96.04M | -2.75M |
| Income Before Tax Ratio | -33.03% | -84.58% | -31.89% | -75.68% | -121.17% | -790.95% |
| Income Tax Expense | 5.39M | -10.77M | 137.78K | -17.05M | 13.17M | 0.00 |
| Net Income | -175.71M | -399.52M | -141.84M | -100.85M | -104.97M | -2.75M |
| Net Income Ratio | -34.36% | -81.32% | -31.10% | -53.36% | -132.44% | -790.95% |
| EPS | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| EPS Diluted | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| Weighted Avg Shares Out | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
| Weighted Avg Shares Out (Dil) | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
3 Marijuana Stocks To Buy Before Federal Reform Becomes Law?
When it comes to market movers for marijuana stocks none has done more than news on federal reform. Historically when progress on the subject is known this creates a rise in trading. The cannabis industry is growing at a fast...
Alan Brochstein On Rescheduling Overexcitement, MSOs, Canada And The Burden Of 280E
Alan Brochstein thinks investors are overly excited about the recent cannabis rescheduling announcement, which is not significant news. The burden of 280E and other financial challenges, debt and income tax payable.
Top U.S. Marijuana Stocks Poised for Growth in Q1 2024
As Q1 2024 unfolds, top US marijuana stocks are capturing investors' attention. The cannabis industry, now legal in many states, is growing rapidly. Legal sales in the US hit $17.5 billion in 2021, with projections suggesting a climb to $43...
The Cannabist Company Announces Debt Repurchase Agreement to Reduce Leverage by up to $25 Million
NEW YORK--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today that, further...
The Cannabist Company Teams up with Revelry to Bring the West Coast Lifestyle Cannabis and Retail Leader to the East Coast
NEW YORK--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., announced today its partnership...
Top U.S. Marijuana Stocks to Watch in Mid-January 2024
As we reach the middle of January 2024, marijuana stocks are becoming increasingly prominent in the investment landscape. This surge in interest is primarily due to the progressive legalization and expanding market opportunities within the cannabis sector globally. In the...
The Cannabist Company Announces Leadership Transition
NEW YORK--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today that, effective...
Here Are Some Of The Top Marijuana Stocks Of 2024
For marijuana stock investors, understanding and effectively navigating the sector's volatility is crucial. One approach is to leverage volatility for strategic gains. Traders often use volatility as an opportunity to capitalize on short-term price movements. By carefully timing entry and...
Marijuana Stocks To Watch Cannabis Investors Are Preparing For 2024
This upcoming year stands to be a crucial year for marijuana stocks. If you are wondering what will be different there has been no sign of volatility slowing up. So what is it that keeps people invested and intrigued? For...
Cannabis Investors - What You Should Know
Nick Gastevich, aka CannaVestments, on Q3 earnings. Focusing on cash flow and profitability, avoiding dilution and adding further debt.
Source: https://incomestatements.info
Category: Stock Reports